Risk of Subclinical Micrometastatic Disease in the Supraclavicular Nodal Bed According to the Anatomic Distribution in Patients With Advanced Breast Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 2, 2008, Pages 435-440

  Reed, Valerie K ^a   Cavalcanti, Jose L ^a   Strom, Eric A ^a   Perkins, George H ^a   Oh, Julia L ^a   Tereffe, Welela ^a   Yu, Tse Kuan ^a   Yeung, Henry ^a   Whitman, Gary J ^a   Bedrosian, Isabelle ^a   Macapinlac, Homer A ^a   Buchholz, Thomas A ^a   Woodward, Wendy A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Positron emission tomography, Computed tomography; Supraclavicular nodes

Indexed keywords

COMPUTERIZED TOMOGRAPHY; ONCOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

SUBCLINICAL MICROMETASTATIC DISEASE; SUPRACLAVICULAR FOSSA;

DISEASES;

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLAVICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE; MICROMETASTASIS; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION FIELD; TISSUE DISTRIBUTION; TREATMENT PLANNING; VERTEBRA BODY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLAVICLE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43049160735     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.10.025     Document Type: Article

References (14)

1. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18 (2000) 2817-2827
2. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
3. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
4. Madu C.N., Quint D.J., Normolle D.P., et al. Definition of the supraclavicular and infraclavicular nodes: Implications for three-dimensional CT-based conformal radiation therapy. Radiology 221 (2001) 333-339
5. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
6. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
7. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
8. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
9. Goodman R.L., Grann A., Saracco P., et al. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast. Int J Radiat Oncol Biol Phys 50 (2001) 99-105
10. Bentel G.C., Marks L.B., Hardenbergh P.H., et al. Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: Is a posterior axillary boost field necessary?. Int J Radiat Oncol Biol Phys 47 (2000) 755-758
11. Dijkema I.M., Hofman P., Raaijmakers C.P., et al. Loco-regional conformal radiotherapy of the breast: Delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 71 (2004) 287-295
12. Schwartz D.L., Ford E., Rajendran J., et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 129-136
13. Taylor A., Rockall A.G., Reznek R.H., et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
14. Lievens Y., Poortmans P., and Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiother Oncol 60 (2001) 257-265